| Literature DB >> 34161644 |
Sridhar Sreeramulu1, Christian Richter1, Hannes Berg1, Maria A Wirtz Martin1, Betül Ceylan1, Tobias Matzel1, Jennifer Adam1, Nadide Altincekic1, Kamal Azzaoui2, Jasleen Kaur Bains1, Marcel J J Blommers2, Jan Ferner1, Boris Fürtig1, Michael Göbel1, J Tassilo Grün1, Martin Hengesbach1, Katharina F Hohmann1, Daniel Hymon1, Bozana Knezic1, Jason N Martins1, Klara R Mertinkus1, Anna Niesteruk1, Stephen A Peter3, Dennis J Pyper1, Nusrat S Qureshi1,4, Ute Scheffer1, Andreas Schlundt5, Robbin Schnieders1, Elke Stirnal1, Alexey Sudakov1, Alix Tröster1, Jennifer Vögele5, Anna Wacker1, Julia E Weigand3, Julia Wirmer-Bartoschek1, Jens Wöhnert5, Harald Schwalbe1.
Abstract
SARS-CoV-2 contains a positive single-stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS-CoV and SARS-CoV-2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex-vivo structural probing experiments. These elements contain non-base-paired regions that potentially harbor ligand-binding pockets. Here, we performed an NMR-based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different 1 H-based 1D NMR binding assays. The screening identified common as well as RNA-element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS-CoV-2.Entities:
Keywords: Covid19-nmr; NMR spectroscopy; RNA; SARS-CoV-2; fragment screening
Year: 2021 PMID: 34161644 DOI: 10.1002/anie.202103693
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336